Profiles of microRNAs in Patients with Advanced Breast Cancer Who are Chemoresistant or Chemosensitive to Fluorouracil, Adriamycin, and Cyclophosphamide Treatment

Key Points

• The aim is to explore the role of microRNAs as biomarkers in identifying breast cancer patients who respond differently to treatment.
• Analyzed microRNA profiles in breast cancer patients
• Grouped patients based on chemosensitivity to fluorouracil, adriamycin, and cyclophosphamide
• Identified potential predictive biomarkers and therapeutic targets
• Certain microRNAs were associated with chemoresistance or chemosensitivity
• MicroRNAs may provide insight into personalized treatment strategies
• Findings suggest that microRNAs could be monitored for treatment responses

Abstract